Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.
Published in: The Journal of Allergy and Clinical Immunology
Date of publication: January 1, 2003
Language: English
Main subject: asthma, patient, antibody, hospitalization
Bibliographic databases:
Cites articles
There is nothing here
Article -